Entry |
|
Name |
Vortioxetine (USAN); Brintellix (TN) |
Formula |
C18H22N2S
|
Exact mass |
298.1504
|
Mol weight |
298.45
|
Structure |

|
Simcomp |
|
Class |
|
Remark |
Product (DG00965): | D10185<JP/US> |
|
Efficacy |
Antianxiety, Antidepressant, Serotonin receptor antagonist |
Comment |
Fluoxetine derivatives, thioether type
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Metabolism |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AX Other antidepressants
N06AX26 Vortioxetine
D10184 Vortioxetine (USAN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01483 5-HT1A-receptor agonist
DG00965 Vortioxetine
D10184 Vortioxetine
Gastrointestinal agent
DG01489 5-HT3-receptor antagonist
DG00965 Vortioxetine
D10184 Vortioxetine
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
DG00965 Vortioxetine
D10184 Vortioxetine
DG02919 CYP2B6 substrate
DG00965 Vortioxetine
D10184 Vortioxetine
DG02918 CYP2C8 substrate
DG00965 Vortioxetine
D10184 Vortioxetine
DG01642 CYP2C9 substrate
DG00965 Vortioxetine
D10184 Vortioxetine
DG01639 CYP2C19 substrate
DG00965 Vortioxetine
D10184 Vortioxetine
DG01644 CYP2D6 substrate
DG00965 Vortioxetine
D10184 Vortioxetine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00965 Vortioxetine
D10184 Vortioxetine
DG02925 CYP3A5 substrate
DG00965 Vortioxetine
D10184 Vortioxetine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR1A
D10184 Vortioxetine (USAN)
Ion channels
Ligand-gated ion channels
Serotonin
HTR3
D10184 Vortioxetine (USAN)
Transporters
Solute carrier family
SLC6
SLC6A4 (HTT)
D10184 Vortioxetine (USAN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10184
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01483 5-HT1A-receptor agonist
DG00965 Vortioxetine
Gastrointestinal agent
DG01489 5-HT3-receptor antagonist
DG00965 Vortioxetine
Metabolizing enzyme substrate
DG01638 CYP2A6 substrate
DG00965 Vortioxetine
DG02919 CYP2B6 substrate
DG00965 Vortioxetine
DG02918 CYP2C8 substrate
DG00965 Vortioxetine
DG01642 CYP2C9 substrate
DG00965 Vortioxetine
DG01639 CYP2C19 substrate
DG00965 Vortioxetine
DG01644 CYP2D6 substrate
DG00965 Vortioxetine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00965 Vortioxetine
DG02925 CYP3A5 substrate
DG00965 Vortioxetine
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 21
1 C8x C 16.6600 -18.2000
2 C8x C 16.6600 -19.6000
3 C8y C 17.8724 -20.3000
4 C8y C 19.0849 -19.6000
5 C8x C 19.0849 -18.2000
6 C8x C 17.8724 -17.5000
7 S2a S 17.8724 -21.6998
8 C8y C 16.6432 -22.4097
9 C8x C 15.4392 -21.7146
10 C8x C 14.2268 -22.4146
11 C8y C 14.2269 -23.8146
12 C8x C 15.4308 -24.5097
13 C8y C 16.6432 -23.8097
14 C1a C 13.0083 -24.5183
15 C1a C 17.8639 -24.5145
16 N1y N 20.3160 -20.3110
17 C1x C 20.3157 -21.6999
18 C1x C 21.5280 -22.4002
19 N1x N 22.7406 -21.7005
20 C1x C 22.7409 -20.3116
21 C1x C 21.5286 -19.6113
BOND 23
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 3 7 1
8 7 8 1
9 8 9 2
10 9 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 8 13 1
15 11 14 1
16 13 15 1
17 4 16 1
18 16 17 1
19 17 18 1
20 18 19 1
21 19 20 1
22 20 21 1
23 16 21 1
|